Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
39956430 | 0 | Hofstetter RV, Stalder O, Tritschler T, et al. Clinical Characteristics and Prognosis of Patients with Central Pulmonary Embolism. J Thromb Haemost. 2025 Feb 14:S1538-7836(25)00072-8. doi: 10.1016/j.jtha.2025.02.007. | |
39870107 | 0 | Hofmann E, Stalder O, Mean M, et al. Anemia and Prognosis in Patients with Acute Venous Thromboembolism. Thromb Haemost. 2025 Jan 27. doi: 10.1055/a-2510-6301. | |
39715559 | 0 | Vale CL, Godolphin PJ, Fisher DJ, et al. Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis. Ann Intern Med. 2025 Jan;178(1):59-69. doi: 10.7326/ANNALS-24-00800. Epub 2024 Dec 24. | |
39249495 | 0 | Stuby J, Stalder O, Limacher A, et al. Baseline platelet count and long-term clinical outcomes in patients with acute venous thromboembolism: a prospective cohort study. Ann Hematol. 2024 Sep 9. doi: 10.1007/s00277-024-05982-8. | |
39214564 | 0 | Khalife R, Burnett AE, Tritschler T, et al. Practical Prescribing: Direct oral anticoagulants. BMJ. 2024 Aug 30;386:e079520. doi: 10.1136/bmj-2024-079520. | |
38938844 | 0 | Godoy LC, Neal MD, Goligher EC, et al. Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19. JACC Adv. 2024 Jan 26;3(3):100780. doi: 10.1016/j.jacadv.2023.100780. eCollection 2024 Mar. | |
37871632 | 0 | Baumgartner C, Tritschler T, Aujesky D. Subsegmental Pulmonary Embolism. Hamostaseologie. 2023 Oct 23. doi: 10.1055/a-2163-3111. | |
37745158 | 0 | Kocher B, Darbellay Farhoumand P, Pulver D, et al. Overuse and underuse of thromboprophylaxis in medical inpatients. Res Pract Thromb Haemost. 2023 Aug 23;7(6):102184. doi: 10.1016/j.rpth.2023.102184. eCollection 2023 Aug. | |
37634309 | 0 | Villiger R, Juillard P, Darbellay Farhoumand P, et al. Prediction of in-hospital bleeding in acutely ill medical patients: External validation of the IMPROVE bleeding risk score. Thromb Res. 2023 Aug 12;230:37-44. doi: 10.1016/j.thromres.2023.08.003. | |
37517478 | 0 | Marx CE, Schenker C, Xu Y, et al. Accuracy and interrater agreement of death event adjudications by physician trainees: Validation of the ISTH definition of pulmonary embolism-related death in an autopsy cohort. J Thromb Haemost. 2023 Jul 28:S1538-7836(23)00577-9. doi: 10.1016/j.jtha.2023.07.015. | |
37364263 | 0 | Khan F, Coyle D, Thavorn K, et al. Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Cost-Effectiveness Study. Ann Intern Med. 2023 Jun 27. doi: 10.7326/M22-3559. | |
37308131 | 0 | Gaugler JO, Righini M, Robert-Ebadi H, et al. Obesity as a Predictor for Pulmonary Embolism and Performance of the Age-Adjusted D-Dimer Strategy in Obese Patients with Suspected Pulmonary Embolism. Thromb Haemost. 2023 Jun 12. doi: 10.1055/s-0043-57018. | |
36858345 | 0 | Schenker C, Marx CE, Kraaijpoel N, et al. Definitions of fatal bleeding in clinical studies evaluating anticoagulant treatment for venous thromboembolism: A scoping review. J Thromb Haemost. 2023 Feb 27:S1538-7836(23)00161-7. doi: 10.1016/j.jtha.2023.02.013. | |
36724651 | 0 | Vrotniakaite-Bajerciene K, Tritschler T, Jalowiec KA, et al. Adherence to thrombophilia testing guidelines and its influence on anticoagulation therapy: A single-center cross-sectional study. Thromb Res. 2022 Dec 15;223:87-94. doi: 10.1016/j.thromres.2022.12.001. | |
36649737 | 0 | Schenker C, Stalder O, Mean M, et al. Bleeding Risk in Elderly Patients with Venous Thromboembolism Who Would Have Been Excluded from Anticoagulation Trials. Thromb Haemost. 2023 Jan 9. doi: 10.1055/s-0042-1760365. | |
36609323 | 0 | Khan F, Thavorn K, Coyle D, et al. Protocol for a modelling study to assess the clinical and cost-effectiveness of indefinite anticoagulant therapy for first unprovoked venous thromboembolism. BMJ Open. 2023 Jan 6;13(1):e053927. doi: 10.1136/bmjopen-2021-053927. | |
36514164 | 0 | Chornenki NLJ, Tritschler T, Stucki F, et al. All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a protocol for a systematic review and meta-analysis. Syst Rev. 2022 Dec 13;11(1):269. doi: 10.1186/s13643-022-02146-5. | |
36357215 | 0 | Tritschler T, Sadeghipour P, Bikdeli B. Subgroup analysis in randomized controlled trials: Useful or misleading? Thromb Res. 2022 Oct 18. pii: S0049-3848(22)00426-1. doi: 10.1016/j.thromres.2022.10.009. | |
35887951 | 0 | Vrotniakaite-Bajerciene K, Tritschler T, Jalowiec KA, et al. Thrombophilia Impact on Treatment Decisions, Subsequent Venous or Arterial Thrombosis and Pregnancy-Related Morbidity: A Retrospective Single-Center Cohort Study. J Clin Med. 2022 Jul 19;11(14). pii: jcm11144188. doi: 10.3390/jcm11144188. | |
35730241 | 0 | Genge L, Krala A, Tritschler T, et al. Evaluation of patients' experience and related qualitative outcomes in venous thromboembolism: A scoping review. J Thromb Haemost. 2022 Jun 22. doi: 10.1111/jth.15788. | |
35717670 | 0 | Tritschler T, Cusano E, Langlois N, et al. Identification of outcomes in clinical studies of interventions for venous thromboembolism in non-pregnant adults: A scoping review. J Thromb Haemost. 2022 Jun 19. doi: 10.1111/jth.15787. | |
35679460 | 0 | Wells PS, Tritschler T, Khan F, et al. Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism. Blood Adv. 2022 Jun 9. pii: 485510. doi: 10.1182/bloodadvances.2022007027. | |
35167861 | 0 | Moores LK, Tritschler T, Brosnahan S, et al. Thromboprophylaxis in Patients with COVID-19. A Brief Update to the CHEST Guideline and Expert Panel Report. Chest. 2022 Feb 12. pii: S0012-3692(22)00250-1. doi: 10.1016/j.chest.2022.02.006. | |
35157815 | 0 | Khan F, Tritschler T, Le Gal G, et al. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism. Ann Intern Med. 2022 Feb;175(2):W14. doi: 10.7326/L21-0731. | |
34753191 | 0 | Khan F, Rahman A, Tritschler T, et al. Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis. Thromb Haemost. 2021 Nov 9. doi: 10.1055/a-1690-8728. | |
34516270 | 0 | Khan F, Tritschler T, Kimpton M, et al. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis. Ann Intern Med. 2021 Oct;174(10):1420-1429. doi: 10.7326/M21-1094. Epub 2021 Sep 14. | |
34379859 | 0 | Khan F, Tritschler T, Kimpton M, et al. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis. J Thromb Haemost. 2021 Nov;19(11):2801-2813. doi: 10.1111/jth.15491. Epub 2021 Aug 22. | |
34351722 | 0 | Goligher EC, Bradbury CA, McVerry BJ, et al. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4. | |
34351721 | 0 | Lawler PR, Goligher EC, Berger JS, et al. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4. | |
34255928 | 0 | Tritschler T, Salvatore SP, Kahn SR, et al. ISTH definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Validation in an autopsy cohort. J Thromb Haemost. 2021 Oct;19(10):2514-2521. doi: 10.1111/jth.15458. Epub 2021 Aug 1. | |
33984268 | 0 | Khan F, Tritschler T, Kahn SR, et al. Venous thromboembolism. Lancet. 2021 Jul 3;398(10294):64-77. doi: 10.1016/S0140-6736(20)32658-1. Epub 2021 May 10. | |
33537525 | 0 | Baumgartner C, Tritschler T. Clinical significance of subsegmental pulmonary embolism: An ongoing controversy. Res Pract Thromb Haemost. 2020 Dec 9;5(1):14-16. doi: 10.1002/rth2.12464. eCollection 2021 Jan. | |
33293309 | 0 | Tritschler T, Langlois N, Hutton B, et al. Protocol for a scoping review of outcomes in clinical studies of interventions for venous thromboembolism in adults. BMJ Open. 2020 Dec 7;10(12):e040122. doi: 10.1136/bmjopen-2020-040122. | |
32888372 | 0 | Tritschler T, Mathieu ME, Skeith L, et al. Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration. J Thromb Haemost. 2020 Nov;18(11):2958-2967. doi: 10.1111/jth.15094. Epub 2020 Oct 1. | |
32502594 | 0 | Moores LK, Tritschler T, Brosnahan S, et al. Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report. Chest. 2020 Sep;158(3):1143-1163. doi: 10.1016/j.chest.2020.05.559. Epub 2020 Jun 2. | |
32496023 | 0 | Tritschler T, Kraaijpoel N, Girard P, et al. Definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Communication from the SSC of the ISTH. J Thromb Haemost. 2020 Jun;18(6):1495-1500. doi: 10.1111/jth.14769. | |
32168402 | 0 | Moumneh T, Riou J, Douillet D, et al. Validation of risk assessment models predicting venous thromboembolism in acutely ill medical inpatients: A cohort study. J Thromb Haemost. 2020 Jun;18(6):1398-1407. doi: 10.1111/jth.14796. Epub 2020 Apr 16. | |
32125293 | 0 | Tritschler T, Castellucci LA, Van Es N, et al. Treatment of venous thromboembolism in elderly patients in the era of direct oral anticoagulants. Pol Arch Intern Med. 2020 Jun 6;130(6):529-538. doi: 10.20452/pamw.15225. Epub 2020 Mar 3. | |
32073218 | 0 | Tritschler T, Kraaijpoel N, Langlois N, et al. Development of a standardized definition of pulmonary embolism-related death: A cross-sectional survey of international thrombosis experts. J Thromb Haemost. 2020 Jun;18(6):1415-1420. doi: 10.1111/jth.14775. Epub 2020 Mar 30. | |
32056070 | 0 | Roberge G, Tritschler T, MacGillivray C, et al. Persisting autoimmune heparin-induced thrombocytopenia after elective abdominal aortic aneurysm repair: a case report. J Thromb Thrombolysis. 2020 Oct;50(3):674-677. doi: 10.1007/s11239-020-02062-2. | |
31683107 | 0 | Stoller N, Limacher A, Mean M, et al. Clinical presentation and outcomes in elderly patients with symptomatic isolated subsegmental pulmonary embolism. Thromb Res. 2019 Dec;184:24-30. doi: 10.1016/j.thromres.2019.10.008. Epub 2019 Oct 22. | |
31661033 | 0 | Khan F, Kimpton M, Tritschler T, et al. Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol. Syst Rev. 2019 Oct 28;8(1):245. doi: 10.1186/s13643-019-1175-5. | |
31301689 | 0 | Kraaijpoel N, Tritschler T, Guillo E, et al. Definitions, adjudication, and reporting of pulmonary embolism-related death in clinical studies: A systematic review. J Thromb Haemost. 2019 Oct;17(10):1590-1607. doi: 10.1111/jth.14570. Epub 2019 Jul 31. | |
31226664 | 0 | Tritschler T, Castellucci LA. It's time for head-to-head trials with direct oral anticoagulants. Thromb Res. 2019 Aug;180:64-69. doi: 10.1016/j.thromres.2019.05.019. Epub 2019 May 31. | |
30860557 | 0 | Tritschler T, Kraaijpoel N, Wells PS. Inferior Vena Cava Filters in the Management of Venous Thromboembolism-Reply. JAMA. 2019 Mar 12;321(10):1007. doi: 10.1001/jama.2018.21127. | |
30826719 | 0 | Lange N, Mean M, Stalder O, et al. Anticoagulation quality and clinical outcomes in multimorbid elderly patients with acute venous thromboembolism. Thromb Res. 2019 May;177:10-16. doi: 10.1016/j.thromres.2019.02.017. Epub 2019 Feb 15. | |
30755438 | 0 | Tritschler T, Wells PS. Extended therapy for unprovoked venous thromboembolism: when is it indicated? Blood Adv. 2019 Feb 12;3(3):499. doi: 10.1182/bloodadvances.2018026518. | |
30529390 | 0 | Zumbrunn B, Stalder O, Mean M, et al. Association between insurance status, anticoagulation quality, and clinical outcomes in patients with acute venous thromboembolism. Thromb Res. 2019 Jan;173:124-130. doi: 10.1016/j.thromres.2018.11.011. Epub 2018 Nov 12. | |
30326130 | 0 | Tritschler T, Kraaijpoel N, Le Gal G, et al. Venous Thromboembolism: Advances in Diagnosis and Treatment. JAMA. 2018 Oct 16;320(15):1583-1594. doi: 10.1001/jama.2018.14346. | |
29307536 | 0 | Lauber S, Limacher A, Tritschler T, et al. Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients. Am J Med. 2018 Jun;131(6):703.e7-703.e16. doi: 10.1016/j.amjmed.2017.12.015. Epub 2018 Jan 4. | |
28594950 | 0 | Mean M, Tritschler T, Limacher A, et al. Association between computed tomography obstruction index and mortality in elderly patients with acute pulmonary embolism: A prospective validation study. PLoS One. 2017 Jun 8;12(6):e0179224. doi: 10.1371/journal.pone.0179224. eCollection 2017. | |
28522384 | 0 | Tritschler T, Limacher A, Mean M, et al. Usefulness of D-Dimer Testing in Predicting Recurrence in Elderly Patients with Unprovoked Venous Thromboembolism. Am J Med. 2017 Oct;130(10):1221-1224. doi: 10.1016/j.amjmed.2017.04.018. Epub 2017 May 15. | |
27606617 | 0 | Hofmann E, Faller N, Limacher A, et al. Educational Level, Anticoagulation Quality, and Clinical Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study. PLoS One. 2016 Sep 8;11(9):e0162108. doi: 10.1371/journal.pone.0162108. eCollection 2016. | |
26341256 | 0 | Tritschler T, Mean M, Limacher A, et al. Predicting recurrence after unprovoked venous thromboembolism: prospective validation of the updated Vienna Prediction Model. Blood. 2015 Oct 15;126(16):1949-51. doi: 10.1182/blood-2015-04-641225. Epub 2015 Sep 4. |